Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients – subgroup analyses from three European clinical trials

References

• Johnson RW, Rice ASC. Postherpetic neuralgia. New Engl J Med 2014;371:1526-33
   PubMed Web of Science ®Google Scholar
• Johnson RW, Wasner G, Saddier P, et al. Herpes zoster and postherpetic neuralgia. Optimizing management in the elderly patient. Drugs Aging 2008;25:991-1006
   PubMed Web of Science ®Google Scholar
• Johnson RW, Bouhassira D, Kassianos G, et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010;8:37
   PubMed Web of Science ®Google Scholar
• Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. J Public Health 2012;20:441-51
   Google Scholar
• Serpell M, Gater A, Carroll S, et al. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes 2014;12:92
   PubMed Web of Science ®Google Scholar
• Mick G, Hans G. Postherpetic neuralgia in Europe: the scale of the problem and outlook for the future. J Clin Gerontol Geriatr 2013;4:102-8
   Google Scholar
• Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9
   PubMed Web of Science ®Google Scholar
• Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009;137:38-47
   PubMed Web of Science ®Google Scholar
• Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010;10:230
   PubMed Web of Science ®Google Scholar
• Cebrián-Cuenca AM, Díez-Domingo J, San-Martín-Rodríguez M, et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis 2011;11:302
   PubMed Web of Science ®Google Scholar
• Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging 2012;29:863-9
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162-73
   PubMed Web of Science ®Google Scholar
• Allegri M, Baron R, Hans G, et al. A pharmacological treatment algorithm for localized neuropathic pain. Curr Med Res Opin 2016;32:377-84
   PubMed Web of Science ®Google Scholar
• Mick G, Baron R, Finnerup NB, et al. What is localized neuropathic pain? A first proposal to characterize and define a widely used term. Pain Manage 2012;2:71-7
   PubMedGoogle Scholar
• Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster − a review. Curr Med Res Opin 2012;28:937-51
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Davies PS, Verkempinck C, et al. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996;65:39-44
   PubMed Web of Science ®Google Scholar
• Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 1999;80:533-8
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, et al. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin 2009;25:1663-76
   PubMed Web of Science ®Google Scholar
• Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy. Interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Invest 2009;29:231-41
   PubMed Web of Science ®Google Scholar
• Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia. Results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Invest 2009;29:393-408
   PubMed Web of Science ®Google Scholar
• Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin 2010;26:1607-19
   PubMed Web of Science ®Google Scholar
• Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-305
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Hans G, Tacken I, et al. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. Curr Med Res Opin 2012;28:1337-46
   PubMed Web of Science ®Google Scholar
• Binder A, Rogers P, Hans G, Baron R. Impact of topical 5% lidocaine medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. Pain Manage 2016;6:229-39
   PubMed Web of Science ®Google Scholar
• Navez ML, Monella C, Bösl I, et al. 5% lidocaine medicated plaster for the treatment of postherpetic neuralgia – a review of clinical safety and tolerability. Pain Ther 2015;4:1-15
   PubMed Web of Science ®Google Scholar
• Sawynok J. Topical analgesics for neuropathic pain in the elderly: current and future prospects. Drugs Aging 2014;31:853-62
   PubMed Web of Science ®Google Scholar
• World Statistics. Health and social statistics. Available at: http://www.infoplease.com/world/statistics/life-expectancy-country.html [Last accessed 6 August 2016]
   Google Scholar
• Guy W. ECDEU assessment manual for psychopharmacology (DHEW Publication no. ADM 76-338). Washington, DC: US Government Printing Office, 1976
   Google Scholar
• Oster G, Harding G, Dukes E, et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 2005;6:356-63
   PubMed Web of Science ®Google Scholar
• Campbell BJ, Rowbotham M, Davies PS, et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci 2002;91:1343-50
   PubMed Web of Science ®Google Scholar
• Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-e88
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85(Suppl.):S3-S14
   Web of Science ®Google Scholar
• Clère F, Delorme-Morin C, George B, et al. 5% Lidocaine medicated plaster in elderly patients with postherpetic neuralgia. Results of a compassionate use programme in France. Drugs Aging 2011;28:693-702
   PubMed Web of Science ®Google Scholar
• Delorme C, Navez ML, Legout V, et al. Treatment of neuropathic pain with 5% lidocaine-medicated plaster: five years of clinical experience. Pain Res Manage 2011;16:259-63
   PubMed Web of Science ®Google Scholar
• Kreitler S, Niv D. Cognitive impairment in chronic pain. Pain: Clinical Updates 2007;15 Available from http://www.iasp-pain.org/PublicationsNews/NewsletterIssue.aspx?ItemNumber=2111 [cited 2016, July 13]
   Google Scholar
• van der Leeuw G, Eggermont LH, Shi L, et al. Pain and cognitive function among older adults living in the community. J Gerontol A Biol Sci Med Sci 2016;71:398-405
   PubMed Web of Science ®Google Scholar
• Pickering G, Pereira B, Clère F, et al. Cognitive function in older patients with postherpetic neuralgia. Pain Pract 2014;14:E1-7
   PubMed Web of Science ®Google Scholar